High body mass index and outcomes of dual antithrombotic therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation undergoing PCI: Results from RE-DUAL PCI

被引：0
|
作者：
De Caterina, R. [1 ]
Lopez Sendon, J. L. [2 ]
Mehta, S. [3 ]
Opolski, G. [4 ]
Oldgren, J. [5 ]
Steg, P. G. [6 ]
Hohnloser, S. [7 ]
Lip, G. Y. H. [8 ]
Kimura, T. [9 ]
Nordaby, M. [10 ]
Kleine, E. [10 ]
Ten Berg, J. M. [11 ]
Bhatt, D. L. [12 ]
Cannon, C. [13 ]
机构：
[1] Univ G dAnnunzio, Chieti, Italy
[2] Univ Hosp La Paz, Madrid, Spain
[3] McMaster Univ, Hamilton, ON, Canada
[4] Med Univ Warsaw, Warsaw, Poland
[5] Uppsala Univ, Uppsala, Sweden
[6] Hosp Bichat Claude Bernard, Paris, France
[7] Goethe Univ Frankfurt, Frankfurt, Germany
[8] Birmingham City Hosp, Birmingham, W Midlands, England
[9] Kyoto Univ, Kyoto, Japan
[10] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[11] St Antonius Hosp, Nieuwegein, Netherlands
[12] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[13] Baim Inst Clin Res, Boston, MA USA
来源：
EUROPEAN HEART JOURNAL | 2018年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P2298
引用
收藏
页码：458 / 458
页数：1
相关论文
共 50 条
  • [31] Toward Brief Dual Antiplatelet Therapy and P2Y12 Inhibitors for Monotherapy After PCI
    Ayoub, Ali
    Ayinapudi, Karnika
    Al-Ogaili, Ahmed
    Panhwar, Muhammad Siyab
    Dakkak, Wael
    LeJemtel, Thierry
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (02) : 153 - 163
  • [32] Antithrombotic therapy after coronary artery stenting in atrial fibrillation: dual therapy encompassing NOAC plus P2Y12 inhibitor is ready for prime time!
    Goette, Andreas
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [33] Optimal Timing of P2Y12 Inhibitor Loading in Patients Undergoing PCI: A Meta-Analysis
    Komosal, Anna
    Lesiak, Maciej
    Krasinski, Zbigniew
    Grygier, Marek
    Siniawski, Andrzej
    Skorupski, Wlodzimierz
    Olasinska-Wgniewska, Anna
    Pyda, Malgorzata
    Araszkiewicz, Aleksander
    Mitkowski, Przemyslaw
    Grajek, Stefan
    Mularek-Kubzdela, Tatiana
    Hengstenberg, Christian
    Siller-Matula, Jolanta M.
    THROMBOSIS AND HAEMOSTASIS, 2019, 119 (06) : 1000 - 1020
  • [34] Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trial
    Lip, Gregory Y. H.
    Mauri, Laura
    Montalescot, Gilles
    Ozkor, Mick
    Vardas, Panagiotis
    Steg, Philippe Gabriel
    Bhatt, Deepak L.
    Hohnloser, Stefan H.
    Miede, Corinna
    Nordaby, Matias
    Brueckmann, Martina
    Kreuzer, Joerg
    Kimura, Takeshi
    Oldgren, Jonas
    ten Berg, Jurrien M.
    Cannon, Christopher P.
    AMERICAN HEART JOURNAL, 2019, 212 : 13 - 22
  • [35] Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)
    Eliaz, R.
    Mengesha, B.
    Ovdat, T.
    Iakobishvili, Z.
    Hasdai, D.
    Kheifets, M.
    Klempfner, R.
    Beigel, R.
    Kalmanovich, E.
    Alcalai, R.
    Levi, A.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1414 - 1414
  • [36] Clinical outcomes by potency of P2Y12 inhibitor following COMBO DTS PCI: From the COMBO collaboration
    Chandrasekhar, J.
    Kalkman, D. N.
    Aquino, M.
    Baber, U.
    Sartori, S.
    Woudstra, P.
    Beijk, M. A.
    Tijssen, J.
    Koch, K. T.
    Dangas, G. D.
    Colombo, A.
    De Winter, R. J.
    Mehran, R.
    EUROPEAN HEART JOURNAL, 2018, 39 : 331 - 332
  • [37] Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting
    Cannon, Christopher P.
    Gropper, Savion
    Bhatt, Deepak L.
    Ellis, Stephen G.
    Kimura, Takeshi
    Lip, Gregory Y. H.
    Steg, Ph. Gabriel
    ten Berg, Jurrien M.
    Manassie, Jenny
    Kreuzer, Jorg
    Blatchford, Jon
    Massaro, Joseph M.
    Brueckmann, Martina
    Ripoll, Ernesto Ferreiros
    Oldgren, Jonas
    Hohnloser, Stefan H.
    CLINICAL CARDIOLOGY, 2016, 39 (10) : 555 - 564
  • [38] Dual antiplatelet therapy with third generation P2Y12 inhibitors in STEMI patients: impact of body mass index on high on-treatment platelet reactivity
    Scudiero, Fernando
    Canonico, Mario Enrico
    Sanna, Giuseppe Damiano
    Avvedimento, Marisa
    Leone, Attilio
    Saba, Pier Sergio
    Silverio, Angelo
    Galasso, Gennaro
    Porto, Italo
    Esposito, Giovanni
    Parodi, Guido
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [39] Dual antiplatelet therapy with third generation P2Y12 inhibitors in STEMI patients: impact of body mass index on high on-treatment platelet reactivity
    Scudiero, Fernando
    Canonico, Mario Enrico
    Sanna, Giuseppe Damiano
    Avvedimento, Marisa
    Leone, Attilio
    Saba, Pier Sergio
    Silverio, Angelo
    Galasso, Gennaro
    Porto, Italo
    Esposito, Giovanni
    Parodi, Guido
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [40] Effect of pretreatment with P2Y12 receptor antagonists on mortality in patients undergoing PCI - A report from SCAAR
    Yan Wenwen
    Wang, Lemin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C100 - C100
12345